Solufenum clinical trials
Also written Ibuprofen Lysine.
A product of Ibuprofen; its studies count on that page too.
How each study uses solufenum is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 13 Apr 2006 · NEOPROFEN · NDA 021903 (FDA, Drugs@FDA)
- European Union
- 28 Jul 2004 · Pedea · EMEA/H/C/000549 (EMA; as Ibuprofen)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2002 (1)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Reckitt Benckiser Healthcare (UK) Limited (2) · Farmacon (1) · OSF Healthcare System (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses solufenum is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Gamma Scintigraphy Study to Investigate Tablet Disintegration in Healthy Volunteers.TerminatedPhase 1Reckitt Benckiser Healthcare (UK) LimitedNCT03497715Written as Ibuprofen lysine
- Ibuprofen and Paracetamol Pharmacokinetic StudyCompletedPhase 1Reckitt Benckiser Healthcare (UK) LimitedNCT02452450Written as Ibuprofen Lysine
- Safety/Efficacy Study of Optimizing Ibuprofen Dosing to Achieve Higher PDA Closure RatesTerminatedPhase 4OSF Healthcare SystemNCT00961753Written as optimized ibuprofen
- Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDACompletedPhase 3FarmaconNCT00440804Written as ibuprofen l-lysine iv solution (NeoProfen (R) )
As the comparator · 2 — what is tested is compared with solufenum
- Impact of Excipients on Pharmacokinetics of OXPzero(TM) IbuprofenCompletedPhase 1Oxford Pharmascience LtdNCT02974361Written as Ibuprofen Lysine
- Study to Investigate the Relative Bioavailability of Ibuprofen in Healthy VolunteersCompletedPhase 1Boehringer IngelheimNCT02183012Written as Ibuprofen lysinate
Codes
What other systems call solufenum · ClinicalTrials.gg INT002640
- MeSH (NLM) C016106solufenumOne source NLM
- UNII (FDA) N01ORX9D6SIBUPROFEN LYSINEConfirmed FDA, NLM
- RxNorm 36761One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C016106 | solufenum | One source NLM |
| UNII (FDA) | N01ORX9D6S | IBUPROFEN LYSINE | Confirmed FDA, NLM |
| RxNorm | 36761 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.